Abiopharma

🔍 SUGAR RONALD D (Executive)

Company: Uber Technologies, Inc (UBER)

Report Date: 2026-05-03

Detailed Transactions and Holdings:

• Acquired 4,091 shares of Common Stock (Direct)
  Date: 2026-05-03 | Code: M | equity_swap_involved: false | shares_owned_after: 4,091.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-03 | Code: H | nature_of_ownership: Trust | shares_owned_after: 231,909.00 | Footnotes: F2
• Sold 4,091 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-03 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Acquired 4,045 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-05 | Code: A | equity_swap_involved: false | shares_owned_after: 4,045.00 | transaction_form_type: 4 | Footnotes: F4, F4

Footnotes:

• F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
• F2: Shares are held by the Sugar Family Trust for which Mr. Sugar serves as trustee.
• F3: The reporting person was granted 4,091 RSUs on May 6, 2025. The RSUs vested on the date immediately preceding the date of the 2026 annual meeting of the stockholders of the Issuer. Upon vesting, the RSUs became payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F4: The reporting person was granted 4,045 RSUs on May 5, 2026 pursuant to Uber's 2019 Equity Incentive Plan. The RSUs are scheduled to vest on the date immediately preceding the date of the 2027 annual meeting of the stockholders of the Issuer, subject to earlier vesting in certain circumstances. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.